Haleon (NYSE:HLN) Hits New 52-Week High - Still a Buy?

Haleon plc (NYSE:HLN - Get Free Report)'s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $11.42 and last traded at $11.42, with a volume of 14380083 shares traded. The stock had previously closed at $11.35.

Analysts Set New Price Targets

A number of research analysts have commented on HLN shares. Barclays reiterated an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a research report on Friday, May 9th. Hsbc Global Res lowered Haleon from a "strong-buy" rating to a "hold" rating in a report on Wednesday, March 5th. HSBC restated a "hold" rating on shares of Haleon in a research report on Wednesday, March 5th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating on shares of Haleon in a research report on Monday, March 3rd. Six investment analysts have rated the stock with a hold rating, four have given a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Stock Down 0.4%

The stock's 50-day moving average is $10.48 and its 200-day moving average is $10.02. The stock has a market cap of $49.84 billion, a P/E ratio of 32.56, a price-to-earnings-growth ratio of 2.82 and a beta of 0.31. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44.

Institutional Trading of Haleon

Institutional investors have recently made changes to their positions in the stock. Wellington Management Group LLP increased its stake in shares of Haleon by 67.5% during the fourth quarter. Wellington Management Group LLP now owns 15,328,325 shares of the company's stock valued at $146,232,000 after acquiring an additional 6,175,835 shares during the period. Nuveen LLC acquired a new position in shares of Haleon during the 1st quarter valued at $58,870,000. Point72 Asset Management L.P. acquired a new position in shares of Haleon during the 4th quarter valued at $45,110,000. Raymond James Financial Inc. bought a new stake in shares of Haleon in the 4th quarter worth $42,193,000. Finally, FMR LLC raised its stake in shares of Haleon by 3.7% in the 4th quarter. FMR LLC now owns 108,827,814 shares of the company's stock worth $1,038,217,000 after buying an additional 3,909,545 shares in the last quarter. 6.67% of the stock is owned by institutional investors and hedge funds.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.